BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,950,000 | +3.7% | 184,894 | 0.0% | 1.95% | -4.1% |
| Q2 2022 | $26,941,000 | +184.0% | 184,894 | +131.1% | 2.04% | +179.8% |
| Q1 2022 | $9,486,000 | -30.6% | 80,000 | -60.0% | 0.73% | +138.7% |
| Q1 2021 | $13,670,000 | -62.5% | 200,000 | -52.9% | 0.30% | -64.8% |
| Q4 2020 | $36,427,000 | +12.1% | 425,000 | -15.0% | 0.87% | -30.6% |
| Q3 2020 | $32,505,000 | -25.9% | 500,000 | -16.7% | 1.25% | -25.3% |
| Q2 2020 | $43,866,000 | +47.2% | 600,000 | -31.5% | 1.67% | +21.0% |
| Q1 2020 | $29,795,000 | -63.5% | 875,551 | -41.6% | 1.38% | -57.5% |
| Q4 2019 | $81,660,000 | +4.0% | 1,500,000 | -20.3% | 3.26% | -31.8% |
| Q3 2019 | $78,492,000 | -14.6% | 1,881,400 | -10.4% | 4.78% | -9.5% |
| Q2 2019 | $91,960,000 | +62.4% | 2,100,000 | +90.9% | 5.28% | +38.0% |
| Q1 2019 | $56,617,000 | +135.5% | 1,100,000 | +69.2% | 3.83% | +96.1% |
| Q4 2018 | $24,037,000 | +146.2% | 650,000 | +150.0% | 1.95% | +207.4% |
| Q3 2018 | $9,763,000 | -13.2% | 260,000 | -8.7% | 0.64% | -23.8% |
| Q2 2018 | $11,253,000 | +53.4% | 284,735 | 0.0% | 0.83% | +52.3% |
| Q1 2018 | $7,335,000 | -8.7% | 284,735 | -4.4% | 0.55% | -35.0% |
| Q4 2017 | $8,035,000 | – | 297,803 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |